The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Biweekly Oxaliplatin (L-OHP) with High-Dose Leucovorin (LV) and 5-Fluorouracil (5-FU) in Irinotecan Pretreated Patients with Advanced Colorectal Cancer (ACC).
 
Pat Gulhati
No Relationships to Disclose
 
Laura Prakash
No Relationships to Disclose
 
Matthew H. G. Katz
Consulting or Advisory Role - Abbvie; Alcresta Therapeutics; McKesson
 
Xuemei Wang
No Relationships to Disclose
 
Milind M. Javle
No Relationships to Disclose
 
Rachna T. Shroff
Consulting or Advisory Role - Agios; Amgen; Celgene; Codiak Biosciences; Halozyme
Research Funding - Agios; Celgene; Lilly
Travel, Accommodations, Expenses - Agios; Amgen; Celgene; Codiak Biosciences; Halozyme
 
David R. Fogelman
Stock and Other Ownership Interests - GTx
Consulting or Advisory Role - Incyte
 
Jeffrey Edwin Lee
No Relationships to Disclose
 
Ching-Wei David Tzeng
No Relationships to Disclose
 
Jeffrey H Lee
Honoraria - Boston Scientific
Consulting or Advisory Role - Boston Scientific
Research Funding - Olympus
Travel, Accommodations, Expenses - Boston Scientific
 
Brian Weston
No Relationships to Disclose
 
Eric P. Tamm
Research Funding - GE Healthcare (Inst)
 
Priya Bhosale
No Relationships to Disclose
 
Eugene Jon Koay
Honoraria - Philips Healthcare
Research Funding - Philips Healthcare
 
Anirban Maitra
Research Funding - Opsona Therapeutics (Inst)
 
Huamin Wang
No Relationships to Disclose
 
Robert A. Wolff
Honoraria - Precision Medicine Research Associates, LLC
Consulting or Advisory Role - Clovis Oncology; Precision Medicine Research Associates, LLC
Patents, Royalties, Other Intellectual Property - Royalties from McGraw-Hill: Editor: M.D. Anderson Manual of Medical Oncology, 3rd edition.
 
Gauri R. Varadhachary
Employment - Fannin Partners (I)
Leadership - Fannin Partners (I); Pulmotect (I)
Stock and Other Ownership Interests - Fannin Partners (I)
Honoraria - Celgene; Merrimack; Momenta Pharmaceuticals; Rexahn Pharmaceuticals
Consulting or Advisory Role - Celgene; Merrimack; Momenta Pharmaceuticals; Rexahn Pharmaceuticals
Research Funding - Merck (Inst)
Patents, Royalties, Other Intellectual Property - Spouse is an inventor of use patents relating to recombinant human lactoferrin. The molecule is no longer in development and patents are being allowed to lapse as payments come due. (I); Spouse is inventor on a pending patent for an ELISA diagnostic platform. Not related to my area of research. (I)
Travel, Accommodations, Expenses - Celgene and Merrimack